A. Nosari, A. Tedeschi, F. Ricci, and M. Montillo. 2008. “Characteristics and Stage of the Underlying Diseases Could Determine the Risk of Opportunistic Infections in Patients Receiving Alemtuzumab”. Haematologica 93 (2). Pavia, Italy, e30-e31. https://doi.org/10.3324/haematol.12465.